Last reviewed · How we verify

NCT03994718

Creative Arts II Study

Completed NA Last updated 28 June 2021
What this trial tests

NA trial testing Music intervention in Epilepsy in 48 participants. Completed in 1 April 2021.

Timeline
30 September 2019
Primary endpoint
1 April 2021
1 April 2021

Quick facts

Lead sponsorDartmouth-Hitchcock Medical Center
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment48
Start date30 September 2019
Primary completion1 April 2021
Estimated completion1 April 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Dartmouth-Hitchcock Medical Center

Who can join

18 and older, any sex, with Epilepsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine the impact of music, visual art, or creative writing on quality of life measures for epilepsy patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Music intervention

Trials testing the same drug.

Other recruiting trials for Epilepsy

Currently open trials in the same condition.

Other Dartmouth-Hitchcock Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03994718.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing